Innovative Diabetes Drug Discovery And Development Partnership Announced By JDRF And GNF
Innovative Diabetes Drug Discovery And Development Partnership Announced By JDRF And GNF
The Juvenile Diabetes Research Foundation has said that it has entered into a novel collaborative research agreement with the Genomics Institute of the Novartis Research Foundation (GNF) to create a diabetes drug discovery and development platform. The four-year program is one of the largest and most comprehensive collaborations in the 40 year history of JDRF, a leader in setting the agenda for diabetes research worldwide and the largest charitable funder and advocate of type 1 research.